1990
DOI: 10.1016/s0002-9610(05)81278-4
|View full text |Cite
|
Sign up to set email alerts
|

Multiple tumors of the biliary tract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
48
0

Year Published

1994
1994
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(49 citation statements)
references
References 9 publications
1
48
0
Order By: Relevance
“…Most are found on removing the gallbladder during a resection for bile duct cancer [4][5][6] . However, metachronous multiple bile duct cancer is very rare.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Most are found on removing the gallbladder during a resection for bile duct cancer [4][5][6] . However, metachronous multiple bile duct cancer is very rare.…”
Section: Discussionmentioning
confidence: 99%
“…Synchronous multiple biliary cancers occur in 3.7%-7.4% of all surgically resected biliary tumors. Most of them develop in the gallbladder and bile duct [4][5][6] . On the other hand, metachronous multiple biliary cancers are rare, with only 11 cases reported in the world literature [7][8][9][10][11][12][13][14][15][16][17] .…”
Section: Introductionmentioning
confidence: 99%
“…Generally, gallbladder carcinoma is called unsuspected gallbladder carcinoma (UGC) when it was found incidentally during or after cholecystectomy because of gallbladder benign diseases [7,8,10,11] . We consider that UGC still includes gallbladder carcinoma found not only during or after cholecystectomy but also in the course of other diseases [12][13][14][15][16][17] . UGC found during cholecystectomy because of acute or chronic cholecystitis was reported in 1961 [18] , but more relative studies and close attention to UGC became available in the 1990s.…”
Section: Introductionmentioning
confidence: 99%
“…Although the histologic and clinicopathologic features of those biliary papillary neoplasms that clinicopathologically resemble pancreatic IPMNs have been described in clinical case reports and several series (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(22)(23)(24)(25), their genetic alterations have only rarely been investigated (11,20). One case of biliary papillomatosis was shown to carry an activating mutation of the K-ras oncogene (11), but we recently found only relatively infrequent K-ras mutations, relatively infrequent allelic losses on chromosomes 5q and 18q, and no evidence for p53/ chromosome 17p alterations in biliary IPNs (20).…”
Section: Discussionmentioning
confidence: 99%